Loading...

NuVasive, Inc.

NUVANASDAQ
Healthcare
Medical - Devices
$39.75
$-0.91(-2.24%)

NuVasive, Inc. NUVA Peers

See (NUVA) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
NUVA$39.75-2.24%2.1B75.00$0.53N/A
ABT$125.83+0.08%219B15.77$7.98+1.86%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$107.76+4.46%159.5B78.67$1.37N/A
SYK$400.93+1.46%153.2B54.18$7.40+0.83%
MDT$92.01+0.39%117.9B25.49$3.61+3.06%
EW$76.91+0.80%45.1B31.78$2.42N/A
DXCM$86.43+1.54%33.9B64.98$1.33N/A
PHG$25.85+3.32%23.9B86.18$0.30+3.45%
STE$225.47+0.80%22.2B36.69$6.15+1.01%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

NUVA vs ABT Comparison

NUVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUVA stands at 2.1B. In comparison, ABT has a market cap of 219B. Regarding current trading prices, NUVA is priced at $39.75, while ABT trades at $125.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUVA currently has a P/E ratio of 75.00, whereas ABT's P/E ratio is 15.77. In terms of profitability, NUVA's ROE is +0.05%, compared to ABT's ROE of +0.32%. Regarding short-term risk, NUVA is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for NUVA.

Stock Price Comparison

Loading...

Frequently Asked Questions

;